Advance | $8,550,000 | (Feb 6, 2026)
Turnstile | $29,000,000 | (Feb 6, 2026)
Accrual | $75,000,000 | (Feb 6, 2026)
Certified by Founder
Lodge
SolasCure
start up
United Kingdom
- Cambridge
- 28/03/2023
- Series B
- $13,422,000
SolasCure leverages biomimicry and evidence-based medicine to develop fit for purpose, efficacious wound care products significantly improve the health and wellbeing of patients.
- Industry Biotechnology Research
- Website https://solascure.com/
- LinkedIn https://www.linkedin.com/company/solascure/
Related People
Sam BakriFounder
United Kingdom -
Cambridge, England
Experienced executive and entrepreneur in life sciences, founded and exited life sciences companies in biopharmaceutical and medical devices.
Connect Music | $80,000,000 | (Feb 6, 2026)
Cadastral | $9,500,000 | (Feb 6, 2026)
Nixtla | $16,000,000 | (Feb 6, 2026)
Nullify | $12,500,000 | (Feb 6, 2026)
Uplift360 | $8,724,008 | (Feb 6, 2026)
Fundamental | $255,000,000 | (Feb 6, 2026)
Duna | $35,365,500 | (Feb 6, 2026)
Flock AI | $6,000,000 | (Feb 6, 2026)